Management of paranasal sinus malignancy

Area of Science:

• Otolaryngology and Head and Neck Surgery
• Oncology
• Radiology

Background:

• Paranasal sinus malignancies (PNSCa) present a wide spectrum of histologies and origins, complicating generalized treatment strategies.
• Epithelial and salivary malignancies, including squamous cell carcinoma and adenoid cystic carcinoma, typically necessitate surgical intervention.
• Nonepithelial malignancies, such as sarcomas, often require multimodal treatment involving chemotherapy, radiation, and surgery.

Purpose of the Study:

• To review current treatment approaches for paranasal sinus malignancies.
• To highlight the role of surgery, chemotherapy, and radiation in managing PNSCa.
• To emphasize the need for further clinical trials to evaluate treatment efficacy and outcomes.

Main Methods:

• Review of existing literature and treatment modalities for paranasal sinus malignancies.
• Discussion of surgical techniques, chemotherapeutic options, and radiotherapeutic strategies.
• Emphasis on the importance of multidisciplinary care and advanced imaging.

Main Results:

• Surgery remains a cornerstone for most epithelial and salivary PNSCa.
• Chemotherapy and radiation are increasingly utilized for advanced-stage disease.
• Surgical advancements have improved functional and cosmetic outcomes in tumor removal and reconstruction.

Conclusions:

• Management of PNSCa requires individualized approaches due to disease heterogeneity.
• Multimodality treatment is often necessary, especially for nonepithelial malignancies.
• Further clinical trials are essential to optimize locoregional control, organ preservation, and survival rates.